Patent details

EP3431492 Title: HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS

Basic Information

Publication number:
EP3431492
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP181699422
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS
French Title of Invention:
PROTÉINES DE LIAISON AU LIGAND DE CD30 HUMAINE
German Title of Invention:
MENSCHLICHES CD30-LIGANDANTIGEN BINDENDE PROTEINE
SPC Number:

Dates

Filing date:
25/04/2013
Grant date:
23/12/2020
EP Publication Date:
23/01/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/12/2020
EP B1 Publication Date:
23/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/04/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/12/2020
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)

Agent

Name:
ARONOVA S.A.
From:
02/03/2021
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
ARMITAGE, Richard J.
Address:
United States (US)

2

Name:
CLARK, Rutilio
Address:
United States (US)

3

Name:
DANTZLER, Jeff
Address:
United States (US)

4

Name:
ANDERSEN, Mette Dahl
Address:
Denmark (DK)

Priority

Priority Number:
201261639637 P
Priority Date:
27/04/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61P 3/04; A61P 3/10; A61P 5/16; A61P 5/38; A61P 13/12; A61P 17/00; A61P 19/02; A61P 21/00; A61P 25/00; A61P 27/02; C07K 14/28; C07K 14/70; C07K 14/705; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202052
Publication date:
23/12/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/03/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
02/03/2021 Power Of Attorney 1
08/03/2021 Outgoing Correspondence 1